Create knowledge
[?]
|
(rate this)
|
|
Core Countries
|
1
|
VS |
1
|
Non Core Countries
|
 |
Sumit Bansal
| Argues in support of
"Non Core Countries"
| 3 years ago
|
|
Economical status and limited access to health care are two important plus point for developing countries. Its is cheap here to conduct clinical research. Sponsors will be able to collect scientific sound data from diverse populations with genetic...
|
|
 |
Sreenivas Hebbare
| Argues in support of
"Core Countries"
| 3 years ago
|
|
Performing the research in the core countries help in getting the funds easily and yes the development process also dos not take much time. If it is non core countries or the developing nations then Lack of control in purchasing drugs in...
|
|
Debate: "Clinical Research in Core vs. Non-Core Countries" deleted from your view.
|
(rate this)
|
|
Safe
|
5
|
VS |
2
|
Not Safe
|
 |
Sudeep Tarafdar
| Argues in support of
"Safe"
| 2 years ago
|
|
ofcourse the Drugs that are manufactured are safe, because there are so many procedures there which are taken care before manufacturing of the drugs starts, there is HACCP( hazard analysis critical control point) and many other things which...
|
|
|
|
Sumit Bansal
| Argues in support of
"Not Safe"
| 3 years ago
|
|
The drugs which are manufactured today are following standards which are set in the year 2004, and now it is 2008 there are many things which are changed. And one thing which has changed to a great extent is the living habit of people and this...
|
|
 |
BEENA AGARWAL
| Argues in support of
"Safe"
| 2 years ago
|
|
Drug manufactured today are based on highly scientific and reliable procedures.There is no question of safety at all.As there are laws and also many experimental proofs to prove the authenticity of a particular drug.Patent law is also applicable...
|
|
Debate: "Safe Drugs" deleted from your view.
|
(rate this)
|
 |
Siddhartha Roy
| Answered
| 2 years ago
|
|
i agree with Mr Sudhakar abt the inclusion of High risk individuals to bring in solid validation and remove distractable noise from trends......
|
|
 |
Bindu Narayan
| Answered
| 3 years ago
|
|
Every medicine/vaccine has to go through human testing before coming to the market. Therefore according to me availability of volunteers would be a great challenge for conducting clinical trials for vaccines.
|
|
 |
Sudhakar Mishra
| Answered
| 3 years ago
|
|
According to me there are two main challenges. These are Recruitment retention of high risk individuals (need long-term follow-up). Defining the right end-points to get a managable trial size. Thanks
|
|
Answer: "What are the key challenges that you face while conducting clinical trials for vaccines?" deleted from your view.
|
(rate this)
|
Well people here are a few things that initiate the development of a new drug. This I have learned from my experience in the pharmaceutical industry over the years. New drugs begin in the laboratory with chemists, scientists and pharmacologists who identify cellular and genetic factors that play a role in specific diseases. They search for chemical and biological substances that target these biological markers and are likely to have drug-like effects. Out of every 5,000 new compounds identified during the discovery process, only five are considered safe for testing in human volunteers after preclinical evaluations. After three to six years of further clinical testing in patients, only one o...
|
|
BEENA AGARWAL
| Commented
| 2 years ago
|
|
Nice basic for drug discovery .These are basics which all pharma industries have to follow befre prducing new drug.Thanks Mr bansal.Nice share
|
|
|
|
Bindu Narayan
| Commented
| 3 years ago
|
|
Great insight. Here many people have the question regarding drug discovery. I hope this will answer their questions to some extent as this article gives a over view of drug discovery process.
|
|
Insight: "How to Discover a new drug?" deleted from your view.
|
(rate this)
|
 |
Gangadhar GangaSagar
| Answered
| 4 years ago
|
|
Sumit has covered this question very nicely. Thanks,
|
|
|
|
Sumit Bansal
| Answered
| 4 years ago
|
|
The following section describes safeguards that protect the safety and rights of volunteer subjects. These safeguards include: The Protocol Review Process Informed Consent Procedures The Patient Representative The Patient Bill of Rights Protocol...
|
|
Answer: "What safeguards are there to protect participants in clinical research? " deleted from your view.
Answer: "Can anyone give me an update on Cancer Medicine?" deleted from your view.
Follow me on
